Search Results - "Perzanowska, Anna"
-
1
Diagnosing pleural effusions using mass spectrometry-based multiplexed targeted proteomics quantitating mid- to high-abundance markers of cancer, infection/inflammation and tuberculosis
Published in Scientific reports (23-02-2022)“…Pleural effusion (PE) is excess fluid in the pleural cavity that stems from lung cancer, other diseases like extra-pulmonary tuberculosis (TB) and pneumonia,…”
Get full text
Journal Article -
2
Molecular Mechanism for Cellular Response to β-Escin and Its Therapeutic Implications
Published in PloS one (11-10-2016)“…β-escin is a mixture of triterpene saponins isolated from the horse chestnut seeds (Aesculus hippocastanum L.). The anti-edematous, anti-inflammatory and…”
Get full text
Journal Article -
3
A Multiplexed Cytokeratin Analysis Using Targeted Mass Spectrometry Reveals Specific Profiles in Cancer-Related Pleural Effusions
Published in Neoplasia (New York, N.Y.) (01-07-2016)“…Abstract Pleural effusion (PE), excess fluid in the pleural space, is often observed in lung cancer patients and also forms due to many benign ailments…”
Get full text
Journal Article -
4
A Multiplexed Cytokeratin Analysis Using Targeted Mass Spectrometry Reveals Specific Profiles in Cancer-Related Pleural Effusions12
Published in Neoplasia (New York, N.Y.) (25-06-2016)“…Pleural effusion (PE), excess fluid in the pleural space, is often observed in lung cancer patients and also forms due to many benign ailments. Classifying it…”
Get full text
Journal Article -
5
Molecular Mechanism for Cellular Response to [beta]-Escin and Its Therapeutic Implications
Published in PloS one (11-10-2016)“…[beta]-escin is a mixture of triterpene saponins isolated from the horse chestnut seeds (Aesculus hippocastanum L.). The anti-edematous, anti-inflammatory and…”
Get full text
Journal Article -
6
An MRM‐Based Cytokeratin Marker Assay as a Tool for Cancer Studies: Application to Lung Cancer Pleural Effusions
Published in Proteomics. Clinical applications (01-03-2018)“…Purpose The goal of this work was to develop an LC‐MRM assay for the quantitative analysis of a set of established and diagnostically important cytokeratin…”
Get full text
Journal Article -
7
Urine proteome of autosomal dominant polycystic kidney disease patients
Published in Clinical proteomics (11-12-2012)“…Autosomal dominant polycystic kidney disease (ADPKD) is responsible for 10% of cases of the end stage renal disease. Early diagnosis, especially of potential…”
Get full text
Journal Article